Cited 20 times in
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.